Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsJaguar Health reports Q1 2026 financial results
Filed May 20, 2026 · Period ending May 20, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release announcing first quarter 2026 financial results on May 20, 2026. Actual figures and performance metrics are contained in the press release exhibit, not in the 8-K body itself.
Item 2.02 verify on EDGAR →
Summary
Jaguar Health filed an 8-K to announce its first quarter 2026 financial results through a press release dated May 20, 2026. This is a routine quarterly earnings disclosure required by SEC regulations. The filing itself does not contain the actual financial figures, revenue numbers, or performance commentary—those details are in the attached press release exhibit.
For retail investors, this represents a standard quarterly update. The key information to review would be in the press release itself: revenue trends, profitability metrics, cash position, and management's outlook commentary. Watch for any guidance updates or material changes in the company's business trajectory when the full results become available. The medium materiality reflects that while earnings announcements are important, the 8-K filing alone provides no substantive financial data to evaluate.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Jaguar Health announced Q1 2026 financial results via press release on May 20, 2026.
Added in current filing · verify on EDGAR →
On May 20, 2026, Jaguar Health, Inc. (the “Company”) issued a press release announcing the first quarter 2026 results.
The company disclosed its first quarter 2026 financial results through a press release. The 8-K itself does not contain the actual financial figures or performance metrics, only references that results were announced. The detailed results would be in the press release exhibit.
Event · Item 9.01 — Financial Statements and Exhibits
Jaguar Health filed an 8-K attaching a press release dated May 20, 2026, with no material business event disclosed in the filing body.
Added in current filing · verify on EDGAR →
Press Release, dated May 20, 2026
The 8-K references an attached press release dated May 20, 2026 (Exhibit 99.1), but the filing body provides no details about the content or subject matter of the press release. Without access to the exhibit itself, the materiality and investor relevance cannot be determined from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify